MASI250117P235000
- 0.00
- 0.000.00%
Masimo Newsroom
Piper Sandler Maintains Masimo(MASI.US) With Buy Rating, Maintains Target Price $210
Needham Maintains Masimo(MASI.US) With Hold Rating
Cautious Optimism Amid Leadership Change and Strategic Uncertainty at Masimo
Masimo's Appointment of Katie Szyman as CEO to Please Investors -- Market Talk
BTIG Maintains Masimo(MASI.US) With Buy Rating, Maintains Target Price $178
BTIG Remains a Buy on Masimo (MASI)
Masimo Names Former Becton Dickinson Executive as CEO, Katie Szyman Takes Over for Board Chair Michelle Brennan
Masimo Appoints Katie Szyman Appointed Chief Executive Officer And To Board Of Directors; Interim CEO Michelle Brennan Named Chairman Of Masimo's Board, Effective February 12, 2025.
Masimo: Changes Are Effective as of Feb 12 >MASI
Express News | Masimo Corp - Michelle Brennan Named Chairman of Masimo's Board
Express News | Masimo Corp -Katie Szyman Appointed Chief Executive Officer and to Board of Directors
Masimo Announces Leadership Transition
Stifel Maintains Masimo(MASI.US) With Buy Rating
GEHC Stock Gains on Long-Term Collaboration With Sutter Health
A Quick Look at Today's Ratings for Masimo(MASI.US), With a Forecast Between $178 to $193
Masimo's Strong Performance and Promising Outlook: Buy Rating Affirmed
Express News | Needham Reiterates Hold on Masimoto Hold
Needham Sticks to Their Hold Rating for Masimo (MASI)
Masimo Announces Preliminary Q4 2024 Revenue At $601M, Up 9%; Healthcare Revenue At $368M, Up 8%; FY24 Revenue At $2.094B, Up 2%; Healthcare Revenue At $1.395B, Up 9%; Non-GAAP EPS Exceeds $4.10; FY25 Guidance Includes Healthcare Revenue Growth Up To...
Express News | Masimo Corp - Full-Year 2024 Non-Gaap EPS Expected to Be More Than $4.10